GGrantIndex
Sort

40,608 grants matching prostate cancer

Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer

$325,775
David Danielpour · Case Western Reserve University · R01 · FY2009 · CA

Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer

$325,775
David Danielpour · Case Western Reserve University · R01 · FY2010 · CA

Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis.

$325,775
Arnold I. Caplan · Case Western Reserve University · R01 · FY2016 · CA

Bone Marrow MSCs/Pericytes: Gatekeepers Controlling Skeletal Metastasis.

$325,775
Arnold I. Caplan · Case Western Reserve University · R01 · FY2015 · CA

Bootstrap-based testing of rare sequence variants using family data

$325,775
Alice S Whittemore · Stanford University · R01 · FY2013 · CA

The Par-4/PKCz complex in prostate cancer

$325,775
Maria Teresa Diaz Meco Conde · University Of Cincinnati · R01 · FY2010 · CA

Characterizing the DNA methylomes of indolent and aggressive prostate cancers

$325,775
Angela H Ting · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · CA

Functional Consequences of Racially Associated Ephrin Alterations on the Prostate Tumor Microenvironment

$325,771
Omar Franco Coronel · Louisiana State Univ Hsc Shreveport · R01 · FY2024 · CA

Lymphatic Imaging

$325,765
Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

The Role of Fgf Signaling in Vertebrate Development

$325,760
Mark Lewandoski · Basic Sciences · Z01 · FY2007 · CA

Automatic Generation of Computer Interpretable Guidelines

$325,760
Daniel Schlegel · College At Oswego · R15 · FY2018 · LM

Elucidating a novel molecular biomarker for castration-resistant prostate cancer

$325,745
Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · CA

14 3 3 Implications in Topoisomerase II Pharmacology

$325,736
Research Triangle Institute · R01 · FY2003 · CA

MicroRNAs in differentiation of muscle

$325,725
Anindya Dutta · University Of Virginia · R01 · FY2007 · AR

High-speed/resolution whole slide scanner supported by two core facilities

$325,700
John S Condeelis · Albert Einstein College Of Medicine · S10 · FY2015 · OD

14 3 3 Implications in Topoisomerase II Pharmacology

$325,697
Research Triangle Institute · R01 · FY2002 · CA

Identification of Methylated Genes in Chronic Lymphocytic Leukemia

$325,653
Christoph Plass · Ohio State University · P01 · FY2007 · CA

"Smart" Nanoparticles for Cancer Therapy and Imaging

$325,649
Joseph M Desimone · Univ Of North Carolina Chapel Hill · U54 · FY2009 · CA

Prostate carcinogenesis and PKC signaling

$325,646
Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2015 · CA

A CLINICAL TRIAL WITH FINASTERIDE AND SELENIUM

$325,641
James Marshall · Roswell Park Cancer Institute Corp · P01 · FY2007 · CA

Generalizable biomedical informatics strategies for predictive modeling of treatment response

$325,640
Antonina Mitrofanova · Rbhs-School/ Health Related Professions · R01 · FY2021 · LM

Generalizable biomedical informatics strategies for predictive modeling of treatment response

$325,640
Antonina Mitrofanova · Rutgers Biomedical And Health Sciences · R01 · FY2023 · LM

Generalizable biomedical informatics strategies for predictive modeling of treatment response

$325,640
Antonina Mitrofanova · Rutgers Biomedical And Health Sciences · R01 · FY2022 · LM

Inhibition of CDK5 as a Treatment for Pancreatic Cancer

$325,622
Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2015 · CA

Metabolic Mechanisms for Programmed Cell Death

$325,557
James M Phang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA